285 related articles for article (PubMed ID: 26093041)
1. In-vivo pharmacology of Trace-Amine Associated Receptor 1.
Lam VM; Espinoza S; Gerasimov AS; Gainetdinov RR; Salahpour A
Eur J Pharmacol; 2015 Sep; 763(Pt B):136-42. PubMed ID: 26093041
[TBL] [Abstract][Full Text] [Related]
2. Trace amine-associated receptor 1: a multimodal therapeutic target for neuropsychiatric diseases.
Schwartz MD; Canales JJ; Zucchi R; Espinoza S; Sukhanov I; Gainetdinov RR
Expert Opin Ther Targets; 2018 Jun; 22(6):513-526. PubMed ID: 29798691
[TBL] [Abstract][Full Text] [Related]
3. Taar1-mediated modulation of presynaptic dopaminergic neurotransmission: role of D2 dopamine autoreceptors.
Leo D; Mus L; Espinoza S; Hoener MC; Sotnikova TD; Gainetdinov RR
Neuropharmacology; 2014 Jun; 81():283-91. PubMed ID: 24565640
[TBL] [Abstract][Full Text] [Related]
4. Trace Amines and Their Receptors.
Gainetdinov RR; Hoener MC; Berry MD
Pharmacol Rev; 2018 Jul; 70(3):549-620. PubMed ID: 29941461
[TBL] [Abstract][Full Text] [Related]
5. TAAR1 as an emerging target for the treatment of psychiatric disorders.
Liu J; Wu R; Li JX
Pharmacol Ther; 2024 Jan; 253():108580. PubMed ID: 38142862
[TBL] [Abstract][Full Text] [Related]
6. Trace Amine Associate Receptor 1 (TAAR1) as a New Target for the Treatment of Cognitive Dysfunction in Alzheimer's Disease.
Leo D; Targa G; Espinoza S; Villers A; Gainetdinov RR; Ris L
Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887159
[TBL] [Abstract][Full Text] [Related]
7. Trace Amines and the Trace Amine-Associated Receptor 1: Pharmacology, Neurochemistry, and Clinical Implications.
Pei Y; Asif-Malik A; Canales JJ
Front Neurosci; 2016; 10():148. PubMed ID: 27092049
[TBL] [Abstract][Full Text] [Related]
8. Pharmacology of human trace amine-associated receptors: Therapeutic opportunities and challenges.
Berry MD; Gainetdinov RR; Hoener MC; Shahid M
Pharmacol Ther; 2017 Dec; 180():161-180. PubMed ID: 28723415
[TBL] [Abstract][Full Text] [Related]
9. Therapeutic Potential of TAAR1 Agonists in Schizophrenia: Evidence from Preclinical Models and Clinical Studies.
Dedic N; Dworak H; Zeni C; Rutigliano G; Howes OD
Int J Mol Sci; 2021 Dec; 22(24):. PubMed ID: 34947997
[TBL] [Abstract][Full Text] [Related]
10. Beta-phenylethylamine alters monoamine transporter function via trace amine-associated receptor 1: implication for modulatory roles of trace amines in brain.
Xie Z; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):617-28. PubMed ID: 18182557
[TBL] [Abstract][Full Text] [Related]
11. Human and mouse trace amine-associated receptor 1 have distinct pharmacology towards endogenous monoamines and imidazoline receptor ligands.
Hu LA; Zhou T; Ahn J; Wang S; Zhou J; Hu Y; Liu Q
Biochem J; 2009 Oct; 424(1):39-45. PubMed ID: 19725810
[TBL] [Abstract][Full Text] [Related]
12. Novel biguanide-based derivatives scouted as TAAR1 agonists: Synthesis, biological evaluation, ADME prediction and molecular docking studies.
Tonelli M; Espinoza S; Gainetdinov RR; Cichero E
Eur J Med Chem; 2017 Feb; 127():781-792. PubMed ID: 27823885
[TBL] [Abstract][Full Text] [Related]
13. Brain-specific overexpression of trace amine-associated receptor 1 alters monoaminergic neurotransmission and decreases sensitivity to amphetamine.
Revel FG; Meyer CA; Bradaia A; Jeanneau K; Calcagno E; André CB; Haenggi M; Miss MT; Galley G; Norcross RD; Invernizzi RW; Wettstein JG; Moreau JL; Hoener MC
Neuropsychopharmacology; 2012 Nov; 37(12):2580-92. PubMed ID: 22763617
[TBL] [Abstract][Full Text] [Related]
14. [Research progress on the immunomodulatory effects and mechanisms of trace amine-associated receptor 1].
Zhang XQ; Li JT; Si TM; Su YA
Sheng Li Xue Bao; 2023 Apr; 75(2):248-254. PubMed ID: 37089099
[TBL] [Abstract][Full Text] [Related]
15. Pharmacological characterization of membrane-expressed human trace amine-associated receptor 1 (TAAR1) by a bioluminescence resonance energy transfer cAMP biosensor.
Barak LS; Salahpour A; Zhang X; Masri B; Sotnikova TD; Ramsey AJ; Violin JD; Lefkowitz RJ; Caron MG; Gainetdinov RR
Mol Pharmacol; 2008 Sep; 74(3):585-594. PubMed ID: 18524885
[TBL] [Abstract][Full Text] [Related]
16. Differential modulation of Beta-adrenergic receptor signaling by trace amine-associated receptor 1 agonists.
Kleinau G; Pratzka J; Nürnberg D; Grüters A; Führer-Sakel D; Krude H; Köhrle J; Schöneberg T; Biebermann H
PLoS One; 2011; 6(10):e27073. PubMed ID: 22073124
[TBL] [Abstract][Full Text] [Related]
17. Trace amine-associated receptors and their ligands.
Zucchi R; Chiellini G; Scanlan TS; Grandy DK
Br J Pharmacol; 2006 Dec; 149(8):967-78. PubMed ID: 17088868
[TBL] [Abstract][Full Text] [Related]
18. Trace amine associated receptor 1 and movement control.
Sotnikova TD; Zorina OI; Ghisi V; Caron MG; Gainetdinov RR
Parkinsonism Relat Disord; 2008; 14 Suppl 2():S99-102. PubMed ID: 18585080
[TBL] [Abstract][Full Text] [Related]
19. Modulation of monoamine transporters by common biogenic amines via trace amine-associated receptor 1 and monoamine autoreceptors in human embryonic kidney 293 cells and brain synaptosomes.
Xie Z; Westmoreland SV; Miller GM
J Pharmacol Exp Ther; 2008 May; 325(2):629-40. PubMed ID: 18310473
[TBL] [Abstract][Full Text] [Related]
20. The Trace Amine-Associated Receptor 1 Agonist 3-Iodothyronamine Induces Biased Signaling at the Serotonin 1b Receptor.
Bräunig J; Dinter J; Höfig CS; Paisdzior S; Szczepek M; Scheerer P; Rosowski M; Mittag J; Kleinau G; Biebermann H
Front Pharmacol; 2018; 9():222. PubMed ID: 29593543
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
